Macitentan attenuates cardiovascular remodelling in infant rats with chronic lung disease.

Baumann, Philipp; Greco, Francesco; Wiegert, Susanne; Wellmann, Sven; Pellegrini, Giovanni; Cannizzaro, Vincenzo

Baumann, Philipp; Greco, Francesco; Wiegert, Susanne; Wellmann, Sven; Pellegrini, Giovanni; Cannizzaro, Vincenzo.

Afiliação

Baumann P; Department of Intensive Care Medicine and Neonatology, University Children's Hospital Zurich, Zurich, Switzerland.
Greco F; Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland.
Wiegert S; Department of Intensive Care Medicine and Neonatology, University Children's Hospital Zurich, Zurich, Switzerland.
Wellmann S; Children's Research Centre, University Children's Hospital Zurich, Zurich, Switzerland.
Pellegrini G; Zurich Centre for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.
Cannizzaro V; Department of Intensive Care Medicine and Neonatology, University Children's Hospital Zurich, Zurich, Switzerland.

J Transl Med ; 20(1): 77, 2022 02 05.

Article em En | MEDLINE | ID: mdl-35123510

Assuntos

Hipertensão Pulmonar; Animais; Humanos; Recém-Nascido; Recém-Nascido Prematuro; Miócitos Cardíacos; Estudos Prospectivos; Pirimidinas; Ratos; Ratos Sprague-Dawley; Sulfonamidas

Palavras-chave

Bronchopulmonary dysplasia; Chronic lung disease; Endothelin receptor blockers; Infants; Preterm; Rats

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipertensão Pulmonar Tipo de estudo: Clinical_trials / Observational_studies Limite: Animals / Humans / Newborn Idioma: En Revista: J Transl Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google